Evidence map›Paper›PMID 31795801›Full record

SynthesisAmerican journal of men's health

Relationship Between Cannabis Use and Erectile Dysfunction: A Systematic Review and Meta-Analysis.

Damiano Pizzol, Jacopo Demurtas, Brendon Stubbs, Pinar Soysal, Corina Mason, Ahmet Turan Isik, Marco Solmi, Lee Smith, Nicola Veronese

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in American journal of men's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. The genetics of cannabis lifetime use.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Update on cannabis in human sexuality.Psychopharmacology · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 3 countries.

Damiano PizzolItalian Agency for Development Cooperation, Jerusalem, Israel.ORCID 0000-0003-4122-0774
Jacopo DemurtasPrimary Care Department Azienda USL Toscana Sud Est, Grosseto, Italy.
Brendon StubbsPhysiotherapy Department, South London and Maudsley NHS Foundation Trust, UK.
Pinar SoysalDepartment of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Corina MasonDepartment of Health Psychology, University of Aberdeen, UK.
Ahmet Turan IsikUnit for Aging Brain and Dementia, Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Marco SolmiDepartment of Neurosciences, University of Padova, Italy.
Lee SmithThe Cambridge Centre for Sport & Exercise Sciences, Anglia Ruskin University, Cambridge, UK.
Nicola VeroneseNational Research Council, Neuroscience Institute, Aging Branch, Padova, Italy.
Anglia Ruskin University · GBAzienda Usl Toscana Centro · ITBezmiâlem Vakıf Üniversitesi · TRDokuz Eylül University · TRKing's College London · GBNeuroscience Institute · ITUniversity of Aberdeen · GBUniversity of Padua · IT

Funding

Department of Health ICA-CL-2017-03-001
6 · The paper itself

Abstract

Globally, there is increasing usage and legalization of cannabis. In addition to its reported therapeutic effects, cannabis has several health risks which are not clearly defined. Erectile dysfunction (ED) is the most common male sexual disorder and there are plausible mechanisms linking cannabis use to ED. No attempt has been made to collate the literature on this topic. The aim of this review was to summarize the prevalence and risk of ED in cannabis users compared to controls. A systematic review of major databases from inception to January 1, 2019, without language restriction, was undertaken to identify studies investigating cannabis use and presence of ED. The analysis compared the prevalence of ED in cannabis users versus controls. Consequently, the odds ratio (OR) with 95% confidence intervals (CI) was calculated, applying a random-effect model. Five case-control studies were included with data from 3,395 healthy men, 1,035 using cannabis (smoking) and 2,360 nonusers. The overall prevalence of ED in cannabis users was 69.1% (95% CI: 38.0-89.1), whilst the correspondent figure in controls was 34.7% (95% CI: 20.3-52.7). The OR of ED in cannabis users was almost four times that of controls (OR = 3.83; 95% CI: 1.30-11.28;

Indexed as

AdultCannabisCase-Control StudiesErectile DysfunctionHumansMaleMarijuana AbuseMiddle AgedPrevalenceReference ValuesRisk AssessmentCannabiserectile dysfunctionmeta-analysisprevalencesystematic review

Identifiers

PMID31795801
PMCPMC6893937
OpenAlexW2989690476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.